Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 5:24 pm Purchase | 2025-09-30 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 199,251 9.990% | 46,032 (+30.04%) | Filing History |
| 2025-07-03 5:25 pm Purchase | 2025-06-27 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 153,219 9.990% | 153,219 (New Position) | Filing History |
| 2024-11-14 7:19 pm Unchanged | 2024-09-30 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 1.900% | 0 (Unchanged) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 18,354 4.990% | 1,753 (+10.56%) | Filing History |
| 2024-06-28 4:15 pm Purchase | 2024-06-28 | 13G | Bone Biologics Corporation BBLG | Ionic Ventures, LLC | 7,181 3.800% | 1,029 (+16.73%) | Filing History |
| 2024-03-14 5:10 pm Purchase | 2024-03-04 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 16,601 9.990% | 16,601 (New Position) | Filing History |
| 2024-02-14 6:41 pm Sale | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | Ionic Ventures, LLC | 6,152 6.500% | -3,046 (-33.11%) | Filing History |
| 2024-02-14 10:55 am Sale | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | Walleye Capital LLC | 0 0.000% | -577 (Position Closed) | Filing History |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 6.000% | 5,697 (New Position) | Filing History |
| 2024-01-02 3:34 pm Purchase | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | SABBY MANAGEMENT LLC | 1,646 11.000% | 787 (+91.60%) | Filing History |
| 2023-12-20 5:21 pm Purchase | 2023-11-16 | 13G | Bone Biologics Corporation BBLG | Ionic Ventures, LLC | 9,198 9.990% | 9,198 (New Position) | Filing History |
| 2023-11-27 06:10 am Purchase | 2023-11-16 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 4,676 4.990% | 4,676 (New Position) | Filing History |
| 2023-06-26 4:50 pm Purchase | 2023-06-16 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 4,230 6.500% | 4,230 (New Position) | Filing History |
| 2023-03-29 4:57 pm Purchase | 2023-03-27 | 13D | Bone Biologics Corporation BBLG | Hankey Don | 4,961 41.700% | 4,961 (New Position) | Filing History |
| 2023-02-14 5:31 pm Purchase | 2022-12-31 | 13G | Bone Biologics Corporation BBLG | Walleye Capital LLC | 577 5.430% | 577 (New Position) | Filing History |
| 2023-02-13 5:23 pm Purchase | 2022-12-31 | 13G | Bone Biologics Corporation BBLG | Ionic Ventures, LLC | 548 4.990% | 33 (+6.48%) | Filing History |
| 2023-01-04 08:10 am Purchase | 2022-12-31 | 13G | Bone Biologics Corporation BBLG | SABBY MANAGEMENT LLC | 859 11.000% | 859 (New Position) | Filing History |
| 2022-10-11 6:22 pm Purchase | 2022-10-11 | 13G | Bone Biologics Corporation BBLG | Ionic Ventures, LLC | 514 5.240% | 514 (New Position) | Filing History |
| 2021-11-01 06:06 am Purchase | 2021-10-15 | 13D | Bone Biologics Corporation BBLG | Hankey Don | 5,332 70.920% | 4,340 (+437.64%) | Filing History |